Xtant Medical
(NYSEMKT) XTNT
Xtant Medical Financials at a Glance
Market Cap
$73.41M
Revenue (TTM)
$133.93M
Net Income (TTM)
$4.97M
EPS (TTM)
$0.03
P/E Ratio
15.69
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$0.52
Volume
897
Open
$0.53
Price
$0.52
Volume
897
Open
$0.53
Previous Close
$0.52
Daily Range
$0.52 - $0.53
52-Week Range
$0.39 - $0.95
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$0.52
Volume
897
Open
$0.53
Previous Close
$0.52
Daily Range
$0.52 - $0.53
52-Week Range
$0.39 - $0.95
XTNT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Xtant Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
151
CEO
Sean E. Browne, MBA
Website
www.xtantmedical.comHeadquarters
Belgrade, MT 59714, US
XTNT Financials
Key Financial Metrics (TTM)
Gross Margin
63%
Operating Margin
5%
Net Income Margin
4%
Return on Equity
11%
Return on Capital
11%
Return on Assets
5%
Earnings Yield
6.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$73.41M
Shares Outstanding
140.07M
Volume
897
Short Interest
0.00%
Avg. Volume
152.25K
Financials (TTM)
Gross Profit
$84.27M
Operating Income
$7.28M
EBITDA
$15.89M
Operating Cash Flow
$12.55M
Capital Expenditure
$2.38M
Free Cash Flow
$10.16M
Cash & ST Invst.
$17.05M
Total Debt
$28.72M
Xtant Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$32.36M
+2.7%
Gross Profit
$17.75M
+10.8%
Gross Margin
54.87%
N/A
Market Cap
$73.41M
N/A
Market Cap/Employee
$338.29K
N/A
Employees
217
N/A
Net Income
$57.00K
+101.8%
EBITDA
$4.13M
+579.7%
Quarterly Fundamentals
Net Cash
$11.66M
+59.7%
Accounts Receivable
$17.80M
-13.8%
Inventory
$30.26M
-21.7%
Long Term Debt
$13.70M
-38.4%
Short Term Debt
$15.01M
+16.5%
Return on Assets
5.28%
N/A
Return on Invested Capital
11.26%
N/A
Free Cash Flow
$4.99M
+71314.3%
Operating Cash Flow
$5.38M
+709.0%